Murray Favus to Osteoporosis, Postmenopausal
This is a "connection" page, showing publications Murray Favus has written about Osteoporosis, Postmenopausal.
Connection Strength
1.128
-
Bisphosphonates for osteoporosis. N Engl J Med. 2010 Nov 18; 363(21):2027-35.
Score: 0.367
-
Postmenopausal osteoporosis and the detection of so-called secondary causes of low bone density. J Clin Endocrinol Metab. 2005 Jun; 90(6):3800-1.
Score: 0.251
-
Comparison of T-scores from different skeletal sites in differentiating postmenopausal women with and without prevalent vertebral fractures. J Clin Densitom. 2005; 8(2):206-15.
Score: 0.244
-
Radiographic texture analysis of densitometer-generated calcaneus images differentiates postmenopausal women with and without fractures. Osteoporos Int. 2006 Oct; 17(10):1472-82.
Score: 0.068
-
Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures. Endocrinol Metab Clin North Am. 2002 Sep; 31(3):659-79, xii.
Score: 0.052
-
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. J Clin Endocrinol Metab. 2000 May; 85(5):1783-8.
Score: 0.044
-
Alendronate in the treatment of postmenopausal osteoporosis. Int J Clin Pract Suppl. 1999 Apr; 101:27-35.
Score: 0.041
-
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995 Nov 30; 333(22):1437-43.
Score: 0.032
-
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int. 2014 May; 25(5):1439-43.
Score: 0.029